Simulations Plus (SLP) announced the extension of two separate research collaborations with the U.S. FDA and the National Institute of Environmental Health Sciences, or NIEHS. The extended projects support ongoing federal research efforts focused on the development of new approach methodologies and advancing computational approaches for food and chemical safety assessments. The extended collaborations align with federal initiatives by supporting research into the application, evaluation, and refinement of computational toxicity models. The extended agreement with the FDA’s Human Foods Program allows scientists to continue research involving computational models to support chemical safety assessments for food-related substances. New federal funding dedicated to food and chemical safety modernization will provide this collaboration with expanded access to curated toxicological datasets for further training, validation, and benchmarking of Simulations Plus’ AI/ML models. The extended collaboration with NIEHS focuses on computational approaches relevant to environmental and exposure-related chemical safety research. NIEHS’ collaboration with Simulations Plus is part of a national effort to modernize chemical safety assessment through AI-powered new approach methodologies and will continue the application of the company’s software engines to help with the design, validation, and benchmarking of new experimental systems under evaluation.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLP:
- Simulations Plus Earnings Call: Growth, Impairment and Caution
- Simulations Plus: Mixed Fundamentals and Full Valuation Support Neutral Stance
- Simulations Plus: Services Outperformance and Improving Software Trends Support Buy Rating Despite Near-Term Softness
- Simulations Plus Posts Mixed Q1 2026 Results, Reaffirms Outlook
- Simulations Plus reports Q1 adjusted EPS 13c, consensus 20c
